Richtlijnen - AZ Sint-Lucas
Richtlijnen - AZ Sint-Lucas
Richtlijnen - AZ Sint-Lucas
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
T, Koike N, Yoshida S, Kashiwagi H, Otsuka M, Fukao K.<br />
Am.Surg. 2001 Sep;67(9):839-43; discussion 843-4. Location, not staging, of cholangiocarcinoma<br />
determines the role for adjuvant chemoradiation therapy.Serafini FM, Sachs D, Bloomston M,<br />
Carey LC, Karl RC, Murr MM, Rosemurgy AS.<br />
Gastrointest. Endoscopy, 2001 May;53(6):547-53. Unilateral versus bilateral endoscopic hepatic<br />
duct drainage in patients with malignant hilar biliary obstruction: results of a prospective,<br />
randomized, and controlled study.De Palma GD, Galloro G, Siciliano S, Iovino P, Catanzano C.<br />
Semin. Oncol. 2002 Dec;29(6 Suppl 20):40-5. Review of gemcitabine in biliary tract carcinoma.<br />
Scheithauer W.<br />
Eur. J. Nucl. Med. Mol. Imag. 2002 Aug;29(8):1047-54. Epub 2002 Jun 1.<br />
Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.Kato<br />
T, Tsukamoto E, Kuge Y, Katoh C, Nambu T, Nobuta A, Kondo S, Asaka M, Tamaki N<br />
Eur. J. Nucl. Med. Mol. Imag. 2002 Oct 1;54(2):414-9.Role of postoperative radiotherapy in the<br />
management of extrahepatic bile duct cancer.Kim S, Kim SW, Bang YJ, Heo DS, Ha SW.<br />
World J. Surg. 2003 Feb;27(2):173-9. Results of postoperative radiotherapy for resectable hilar<br />
cholangiocarcinoma.Gerhards MF, van Gulik TM, González González D, Rauws EA, Gouma DJ.<br />
Gastrointestinal endoscopy, 2003 Feb;57(2):178-82. Plastic or metal stents for malignant stricture<br />
of the common bile duct? Results of a randomized prospective study.<br />
Kaassis M, Boyer J, Dumas R, Ponchon T, Coumaros D, Delcenserie R, Canard JM, Fritsch J, Rey JF,<br />
Burtin P.<br />
Ann. of oncology 2004 Sep;15(9):1339-43. Gemcitabine combined with oxaliplatin (GEMOX) in<br />
advanced biliary tract adenocarcinoma: a GERCOR study. André T, Tournigand C, Rosmorduc O,<br />
Provent S, Maindrault-Goebel F, Avenin D, Selle F, Paye F, Hannoun L, Houry S, Gayet B, Lotz JP,<br />
de Gramont A, Louvet C; GERCOR Group.<br />
J. Clin. Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition); Vol 27, No 15S<br />
(May 20 Supplement), 2009: 4503. Gemcitabine with or without cisplatin in patients (pts) with<br />
advanced or metastatic biliary tract cancer (ABC): Results of a multicenter, randomized phase III<br />
trial (the UK ABC-02 trial). J. W. Valle, H. S. Wasan, D. D. Palmer, D. Cunningham, D. A. Anthoney,<br />
A. Maraveyas, S. K. Hughes, M. Roughton and J. A. Bridgewater<br />
Ann. of Oncology 2009;20:1369-1374. Feasibility of radiotherapy with concomitant gemcitabin<br />
and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective<br />
dose finding phase I-II study. Laurent S., Monsaert E., Boterbert T. et al.<br />
J. Clinical Oncology 29: 2011 (suppl. Abstracts ASCO LBA 4006), Ampullary Cancer ESPAC-3(v2)/<br />
Oral abstract session. J. Neoptolemos et al.<br />
Jap. J. Clin. Onoclogy, 2011; 41 (2) 217-224. A phase II study of outpatient biweekly Gemcitabin-
Change language